Biomaterials Translational

About Biomaterials Translational

About Biomaterials Translational

Biomaterials Translational is a peer-reviewed scholarly journal published by Chinese Medical Multimedia Press Co Ltd (China). It focuses on Q1. Publication coverage spans 2020-2025.

Key indicators: ISSN 2096-112X; H-index 25.

Understanding This Journal's Metrics

Journal metrics help researchers assess fit, but they must be interpreted in context:

• H-index (25): 25 articles have each received at least 25 citations, indicating growing recognition.

Publishing in Biomaterials Translational

When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.

• Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
• Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.

Is This Journal Right for Your Paper?

• Audience match: Will the journal's readers cite and build on your findings?
• Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
• Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
• Open access needs: Check funder mandates and whether the journal offers compliant OA options.

Frequently Asked Questions

What is the ISSN of Biomaterials Translational?
2096-112X.

Who publishes Biomaterials Translational?
Chinese Medical Multimedia Press Co Ltd.

What are Biomaterials Translational's metrics?
H-index 25.

Is Biomaterials Translational peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.